ABL Bio Inc. (298380.KQ) KOE

188,000.00

-6600(-3.39%)

Updated at February 20 03:30PM

Currency In KRW

Valuation

Market Cap10.77T
Enterprise Value10.77T
P/E Ratio-267.48
PEG Ratio11.53
Price/Sales Ratio130.61
Price/Book Ratio55.54
Enterprise/Revenue129.59
Enterprise/EBITDA-283.65

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.48
Operating Margin-0.51

Management Effectiveness

Return On Assets-0.16
Return On Equity-0.22

Income Statement

Revenue79.35B
Revenue/Share1,473.51
Gross Profit0
EBITDA-40.39B
Net Income-37.88B
Diluted EPS-703.38

Balance Sheet

Total Cash127.2B
Total Cash/Share2,362.1
Total Debt43.48B
Total Debt/Equity0.24
Current Ratio2.53
Book Value Per Share3,383.75

Price History

52-Week Change380.82
52-Week High257,500
52-Week Low31,300
Moving Average 50 Days197,796
Moving Average 200 Days117,360

Statistics

Average Volume1.28M
Shares Outstanding55.13M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A